In summary, our study endorses that the EGFR-mTORC2-RICTOR-AKT-UGCG-Ganglioside circuit regulates tumor progression in luminal breast cancer cells and provides us with an opportunity to intervene at multiple nodes to tame cancer cells. This evidence concerns the gene AKT1 and breast carcinoma.